Xu X, Li B, Wang L: Gender difference in smoking effects on adult pulmonary function.
Eur Respir J 1994, 7:477–483.
Leidy NK, Traver G: Psychophysiologic factors contributing to functional performance in people with COPD: are there gender differences?
Research in Nursing and Health 1995, 18:535–546.
Becklane MR, Kauffmann F: Gender differences in airway behaviour over the human life span.
Thorax 1999, 54:1119–1138.
ATS official statement. Dyspnea. Mechanisms, Assessment, and Management: A Consensus StatementAm J Respir Crit Care Med 1999, 159:321–340.
Gonzalez E, Herrejon A, Inchaurraga I, Blanquer R: Determinants of health-related quality of life in patients with pulmonary emphysema.
Respir Med 2005, 99:638–644.
Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC: Chronic Pulmonary Disease Surveillance- United States, 1971–2000.
MMWR 2002, 51:SS6.
de Torres JP, Casanova C, Hernandez C, Abreu J, Aguirre-Jaime A, Celli BR: Gender and COPD in patients attending a pulmonary clinic.
Chest 2005, 128:2012–2016.
Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, mendez RA, Pinto-Plata V, Cabral HJ: The body mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease.
N Engl J Med 2004, 350:1005–1012.
Brooks SM: Surveillance for respiratory hazards.
ATS News 1982, 8:12–16.
Gift AG: Validation of a vertical visual analogue scale as a measure of clinical dyspnea.
Rehabil Nurs 1989, 14:323–325.
ATS Statement: Guidelines for the Six-Minute Walk TestAm J Respir Crit Care Med 2002, 166:111–117.
Charlson M, Szatrowski TP, Peterson J, Gold G: Validation of a combined comorbility index.
J Clin Epidemiol 1994, 47:1245–1251.
Quanjer PH: Standardized lung function testing. Report of the Working Party for the European Community for Steel and Coal.
Bull Eur Physiopath Respir 1983,19(supp 5):22–27.
Marin JM, Carrizo SJ, Gascon M, Sanchez A, Gallego B, Celli BR: Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 2001, 163:1395–1399.
Black LF, Hyatt RE: Maximal respiratory pressures: normal values and relationship to age and sex.
Am Rev Respir Dis 1969, 9:696–702.
Burki NK, Mitchell LK, Chaudhary BA, Zechman FW: Measurement of mouth occlusion pressure as an index of respiratory centre output in man.
Clin Sci Mol Med 1977, 53:117–123.
de Torres JP, Talamo C, Aguirre-Jaime A, Rassulo J, Celli B: Electromyographic validation of the pressure-time index: a non-invasive assessment of inspiratory muscle load.
Respir Med 2003, 97:1006–1013.
Pauwels RA, Buist AS, Calverley PM, jenkins CR, Hurd SS, GOLD Scientific Committee: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.
Am J Respir Crit Care Med 2001, 163:1256–1276.
Nishimura K, Izumi T, Tsukino M, Oga T: Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.
Chest 2002, 121:1434–1440.
Calverley PM, Walker P: Chronic obstructive pulmonary disease.
Lancet 2003, 27;362:1053–1061.
PAARC. Group Coopératif: Pollution atmosphérique et affections respiratoires chroniques ou á répétition.
Bull Eur Physiopathol Respir 1982, 18:87–99.
Marin JM, Montes de Oca M, Rassulo J, Celli BR: Ventilatory drive at rest and perception of exertional dyspnea in severe COPD.
Chest 1999, 115:1293–1300.
Kimura H, Tatsumi K, Kunitomo F, Okita S, Tojima H, Kouchiyama S, Masuyama S, Shinozaki T, Honda Y, Kuriyama T: Progesterone therapy for sleep apnea syndrome evaluated by occlusion pressure responses to exogenous loading.
Am Rev Respir Dis 1989, 139:1198–1206.
Parker TA, Afshar S, Kinsella JP, Grover TR, Gebb S, Geraci M, Shaul PW, Cryer CM, Abman SH: Effects of chronic estrogen-receptor blockade on ovine perinatal pulmonary circulation.
Am J Physiol Heart Circ Physiol 2001, 281:H1005–14.
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA: Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.
Thorax 1999, 54:581–586.
O'Donnell DE: Ventilatory limitations in chronic obstructive pulmonary disease.
Med Sci Sports Exerc 2001, 33:S647–55.
Casanova C, Cote C, de Torres JP, Aguirre-jaime A, Marin JM, Pinto-Plata V, Celli BR: The Inspiratory to Total Lung Capacity Ratio Predicts Mortality in Patients with COPD.
Am J Respir Crit Care Med 2004, 171:591–597.
O'Donnell DE, Webb KA: Breathless in patients with severe chronic airflow limitation. Physiologic correlations.
Chest 1992, 102:824–831.
Sahebjami H, Sathianpitayakul E: Influence of Body Weight on the Severity of Dyspnea in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med 2000, 161:886–890.
Oga T, Nishimura K, Tsukino M, Hajiro T, Mishima M: Dypnea with activities of daily living versus peak dypsnea during exercise in male patients with COPD.
Respir Med 2006, 100:965–71.
Gallego MC, Samaniego J, Alonso J, Sanchez A, Carrizo S, Marin JM: Dyspnea in COPD: relation to the MRC scale with dyspnea induced by walking and cardiopulmonary stress testing.
Arch Bronconeumol 2002, 38:112–116.
Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, Allegra L, Centanni S: Anxiety and depression in COPD patients: The roles of gender and disease severity.
Respir Med 2006, 100:1767–74.
Ninot G, Fortes M, Poulain M, Brun A, Desplan J, Prefaut C, Varray A: Gender difference in coping strategies among patients enrolled in an inpatient rehabilitation program.
Heart Lung 2006, 35:130–136.
Lapperre TS, Snoeck-Stroband JB, Gosman MM, Stolk J, Sont JK, Jansen DF, Kerstjens HA, Postma DS, Sterk PJ, Groningen and Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group: Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 2004, 170:499–504.